Percutaneous Cryoablation Peripheral Lung Cancer

Shanghai Chest Hospital30 enrolled

Overview

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Lung Cancer

Interventions

Percutaneous cryoablationPROCEDURE

Percutaneous cryoablation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: medically inoperable peripheral lung cancer Diameter no more than 3cm Exclusion Criteria: 1. Refusal of participation 2. tendency to bleed to that can't receive percutaneous cryoablation. 3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

Outcomes

Primary Outcomes

PFS

Time frame: 2 years

Secondary Outcomes

Time frame: 2 years

Central Contacts

Sun jiayuan, MD

CONTACT

18017321598

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.